OncoCyte Corporation OCX
3.20 0.00 (+0.00%)
At closeJun 17, 2025, 4:00 PM EDT
2.82 Day range 3.20
52-week range unavailable
- YTD
- +34.45%
- 1 year
- +15.94%
OCX revenue history
Revenue is income from the company’s ordinary business activities.
1,881,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 1,881,000 | 378,000 | 25.15% |
| FY 2023 | 2023-12-31 | 1,503,000 | 545,000 | 56.89% |
| FY 2022 | 2022-12-31 | 958,000 | -1,240,000 | -56.41% |
| FY 2021 | 2021-12-31 | 2,198,000 | 982,000 | 80.76% |
| FY 2020 | 2020-12-31 | 1,216,000 | 1,216,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-05-16T14:03:06.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.